Novel Coronavirus 2019 (COVID-19)

The Osteopathic Medical Board remains open as we perform essential governmental functions to license and regulate osteopathic physicians and surgeons who are on the front lines of the Coronavirus (COVID-19) pandemic. Should you experience any delays in reaching staff during this time, we appreciate your patience and apologize for any inconvenience in advance.

Alert Alert:

New: New changes to PTL licenses FAQs

New: CURES Data Collection Vendor Change – Action Required by February 23, 2022
The California Department of Justice (DOJ) recently awarded the contract for prescription data collection services for the Controlled Substance Utilization Review and Evaluation System (CURES) to a new vendor. For information on how licensees of DCA boards are impacted by this change, please see the New Data Collection Vendor For Cures document on the DOJ CURES webpage.

New: Licensing Laws Take Effect January 1, 2022

New: CDPH: Monoclonal Antibody Treatment Information for Providers and Facilities

New: CDPH: Direct Ordering of Monoclonal Antibodies

New: New Prescribing Laws Take Effect January 1, 2022.
Licensees of the Osteopathic Medical Board of California with prescribing authority are subject to the e-prescribing requirements established by Assembly Bill (AB) 2789 (Wood, 2018). Beginning January 1, 2022, most prescriptions (including but not limited to prescriptions for controlled substances) issued by a licensed healthcare practitioner to a California pharmacy must be submitted electronically. For more information on this law and its requirements, please see the AB 2789 bulletin. Practitioners also can get answers to questions about complying with the law at Electronic Data Transmission Prescriptions (E-Prescriptions) – Frequently Asked Questions provided by the California State Board of Pharmacy.

New: Telehealth Information Pursuant to Executive Order N-16-21

New: Health Care Workers and Vaccination Requirements

SCAM ALERT: Fake Board Representative or DEA Agent Extortion Scam

New: CURES Fee Increase Effective April 1, 2021

COVID19 Update: Beginning March 15, COVID-19 vaccine eligibility has expanded. Read the CDPH provider bulletin for details:

New: How To Get Vaccinated
Learn more about how to get vaccinated by visiting the state’s COVID-19 website → The state’s website has information on vaccination eligibility, how to sign up for an appointment via, local health jurisdiction resources, and more. Additionally, CVS, Rite Aid and Walgreen pharmacies now offer limited appointments for free COVID-19 vaccinations in select areas. Visit for more information.

New: AB 2113 - Expedited Licensure for Refugee Status Outreach

New: Notice Regarding COVID-19 Vaccine Administration

New: Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021

New: AB 149 - New requirements for controlled substances prescription forms

New: Emergency Medical Services Authority (EMSA) - Waivers

The Osteopathic Medical Board would like to notify you that the Cybersecurity & Infrastructure Security Agency, Federal Bureau of Investigation, and the Department of Health and Human Services have credible information of an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers. The Osteopathic Medical Board is sharing this information to provide warning to healthcare providers to ensure that they take timely and reasonable precautions to protect their networks from these threats. Please see additional information at the Cybersecurity & Infrastructure Security Agency website:

Department of Health Care Services to all health care licensees

Essential versus Non-Essential Services

Notice to Stakeholders Novel Coronavirus 2019 (COVID-19)

CDPH What You Need To Know: Novel Coronavirus 2019 (COVID-19)

New: EXCITING OPPORTUNITY: Apply to become an Expert Reviewer

Apply for Board appointments here

CURES Mandatory Use Begins October 2, 2018

Mission Statement

To protect consumers and promote the highest professional standards in the practice of osteopathic medicine, the Osteopathic Medical Board of California licenses osteopathic physicians and surgeons.

The board investigates consumer complaints and uses its enforcement power to ensure practitioners abide by the provisions of the state Business and Professions Code/Medical Practice Act.

To maintain their license, practitioners must successfully complete rigorous, periodic continuing education requirements that meet the standards of the American Osteopathic Association (AOA).


The Controlled Substance Utilization Review and Evaluation System (CURES) was certified for statewide use by the Department of Justice on April 2, 2018. Therefore, the mandate to consult CURES prior to prescribing, ordering, administering, or furnishing a Schedule II-IV controlled substance becomes effective on October 2, 2018.

CURES contains the following information: patient name, patient date of birth, patient address, prescriber name, prescriber DEA number, pharmacy name, pharmacy license number, date prescription was dispensed, prescription number, drug name, drug quantity and strength, and number of refills remaining.